Earn CME: https://naccme.com/program/19-gdugi-5 In this webcast from the ‘Making Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing’ symposium during the 2019 Great Debates & Updates in Gastrointestinal Malignancies conference, Dr. Tanios S. Bekaii-Saab presents a case of advanced HCC that elucidates the role of immunotherapy. © 2019 Imedex, an HMP Company
Related Posts
NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022]
Liver
14 Mins Read
NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022]
Liver
14 Mins Read